MiRNA137 Mimics Targeting MCL-1 as a Novel Therapeutic Agent in Preclinical Models of Multiple Myeloma

被引：0
|
作者：
Yang, Y. [1 ]
Saha, M. N. [1 ]
Chen, Y. [1 ]
Chang, H. [1 ]
机构：
[1] Univ Hlth Network, Toronto, ON, Canada
来源：
LABORATORY INVESTIGATION | 2014年 / 94卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1922
引用
收藏
页码：468A / 469A
页数：2
相关论文
共 43 条
  • [41] Targeting of the E3 ubiquitin-protein ligase HUWE1 impairs DNA repair capacity and tumor growth in preclinical multiple myeloma models
    Viktoria Kunz
    Kathryn S. Bommert
    Jessica Kruk
    Daniel Schwinning
    Manik Chatterjee
    Thorsten Stühmer
    Ralf Bargou
    Kurt Bommert
    Scientific Reports, 10
  • [42] Novel Oncolytic Therapy VET3-TGI Restricts TGFb1 and Augments Type1 Immune Response in TME, Leading to Superior Therapeutic Efficacy in Multiple Preclinical Tumor Models
    Muthuswamy, Ravi
    Carter, Carly
    Zhang, Ming
    Byrd, Dan
    Thorne, Steve
    MOLECULAR THERAPY, 2023, 31 (04) : 157 - 157
  • [43] Inhibition of WEE1 Induces Cell Death of Both Bortezomib- and Lenalidomide-Resistant Multiple Myeloma Cells: A Novel Therapeutic Approach Targeting Cell-Cycle Checkpoint Kinase
    Tabayashi, Takayuki
    Tanaka, Yuka
    Takahashi, Yasuyuki
    Kimura, Yuta
    Tomikawa, Tatsuki
    Sagawa, Morihiko
    Anan-Nemoto, Tomoe
    Watanabe, Reiko
    Tokuhira, Michihide
    Kizaki, Masahiro
    BLOOD, 2016, 128 (22)
12345